Picture of Cidara Therapeutics logo

CDTX — Cidara Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Cidara Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

* Cidara Therapeutics Inc  CDTX.OQ  reported a quarterly
adjusted
loss of 4 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -19 cents.  The mean expectation of
four analysts for the quarter was for a loss of 10 cents per
share. Wall Street expected results to range from -16 cents
to -7 cents per share.
    * Revenue rose 72.1% to $17.58 million from a year ago;
analysts
expected $11.54 million. 
    * Cidara Therapeutics Inc's reported EPS for the quarter was
a
loss of 4 cents​.
    * The company reported a quarterly loss of $3.21 million.
    * Cidara Therapeutics Inc shares had fallen by 26.0% this
quarter and lost 14.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Cidara
Therapeutics Inc is $5.50 
This summary was machine generated from LSEG data April 22 at
10:11 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.10          -0.04          Beat
 Sep. 30 2023      -0.16          -0.09          Beat
 Jun. 30 2023      -0.13          -0.14          Missed
 Mar. 31 2023      -0.04          0.03           Beat

Recent news on Cidara Therapeutics

See all news